滚动资讯
FierceBiotechMirum maps FDA path after anti-itch candidate scores ph. 2 winNovartisAfter March cuts, Novartis trims another 60 roles at US headquarters - Fierce PharmaFierceBiotechTakeda pivotal trial win improves convenience for PID patients relative to HyQviaBioWorldBiggest gainers and losers for April 27-May 1, 2026Endpoints NewsCelcuity breast cancer win; Odyssey plans $205M IPO; Latus Bio extends Series AFierceBiotechWindward获1.65亿美元融资,推动长效TSLP研发雄心Endpoints News生物科技迎来新型初创模式:小团队、高投资、中国资产Thermo Fisher赛默飞世尔科技推出Gibco CTS DynaXS一次性生物反应器PfizerPfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era - Yahoo FinanceSiemens HealthineersCDC HoST-TT Certification for Siemens Healthineers Total Testosterone Test Expands Patient Access to Gold Standard Equivalent Results - The Manila TimesSiemens HealthineersSiemens Healthineers testosterone assay maintains CDC certification By Investing.com - Investing.com CanadaPharmaVoiceArvinas获得里程碑式批准,蛋白质降解剂研发提速
Lonza News 2026年1月23日

细胞疗法生物加工市场即将迎来繁荣 |• 龙沙 • 赛默飞世尔科技 - openPR.com

细胞疗法生物加工市场即将迎来繁荣 |• 龙沙 • 赛默飞世尔科技 - openPR.com

暂时没有全文,请查看原始来源。